Citations

Clear

3030 citation(s) found for "Susan, M".

Patient Concept Elicitation Interviews: Insights into Multiple System Atrophy (MSA) Patient Experiences and Relevance of a modified United Multiple System Atrophy Rating Scale (P8-9.003)
Potashman, Michele , Huang, Isabella , Durham, Susan, Wirtz, Victoria, L’Italien, Gilbert , Coric, Vladimir, Palma, Andrea De , Brion, Triza , Low, Phillip A. , Qureshi, Irfan , Huang, Isabella, Durham, Susan, Höglinger, Günter U. , Kaufmann, Horacio , McFarland, Nikolaus R. , Meissner, Wassilios G. , Millar Vernetti, Patricio , Morris, Huw R. , Poewe, Werner H , Seppi, Klaus , Singer, Wolfgang , Vernino, Steven

Mayo Clinic

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000202288 Get It

Psychometric Validation of a Modified United Multiple System Atrophy Rating Scale (S43.002)
Potashman, Michele , Brady, Lila, Durham, Susan, Wirtz, Victoria, L’Italien, Gilbert , Coric, Vladimir, Low, Phillip A. , Qureshi, Irfan , Durham, Susan, Höglinger, Günter U. , Kaufmann, Horacio , McFarland, Nikolaus R. , Meissner, Wassilios G. , Millar Vernetti, Patricio , Morris, Huw R. , Poewe, Werner H , Seppi, Klaus , Singer, Wolfgang , Vernino, Steven

Mayo Clinic

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000202223 Get It

Correlates of Fluctuations in Moderate-Advanced Dementia with Lewy Bodies (P13-6.007)
Tholanikunnel, Tracy , LaBarre, Brian , Sovich, Kaitlin , Paulson, Henry L. , Maixner, Susan M. , Manning, Carol A. , Fields, Julie A. , Lunde, Angela , Boeve, Bradley, Forsberg, Leah K. , Armstrong, Melissa J. , Paulson, Henry L , LaBarre, Brian , Armstrong, Melissa J , Li, Zhigang , Galvin, James E. , Taylor, Angela E.

Mayo Clinic

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000202132 Get It

Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?
Cabrera-Serrano, Antonio José , Sánchez‐Maldonado, José Manuel , Macauda, Angelica , García-Martín, Paloma, Benavente, Yolanda , Landi, Stefano , Clay‐Gilmour, Alyssa , Niazi, Yasmeen , Espinet, Blanca , Rodríguez‐Sevilla, Juan José , Pérez, Eva María, Maffei, Rossana , Blanco, Gonzalo , Giaccherini, Matteo , Marasca, Roberto , López‐Nevot, Miguel Ángel , Thomsen, Hauke , Gámez, Irene, Campa, Daniele , Moreno, Vı́ctor , Sanjosé, Sílvia de , Marcos‐Gragera, Rafael , García‐Álvarez, María , Dierssen‐Sotos, Trinidad , Jerez, Andrés , Butrym, Aleksandra , Hemminki, Kari , Li, Yang , Berndt, Sonja I. , Casabonne, Delphine , Alcoceba, Miguel , Puiggros, Anna , Netea, Mihai G. , Försti, Asta , Canzian, Federico , Sáinz, Juan , Benavente, Yolanda , Landi, Stefano , Espinet, Blanca , Rodríguez-Sevilla, Juan José , Maffei, Rossana , Blanco, Gonzalo , Giaccherini, Matteo , Marasca, Roberto , López-Nevot, Miguel Ángel , Thomsen, Hauke , Moreno, Victor , Marcos-Gragera, Rafael , Dierssen-Sotos, Trinidad , Jerez, Andrés , Butrym, Aleksandra , Hemminki, Kari , Li, Yang , Alcoceba, Miguel , Puiggros, Anna , Försti, Asta , Canzian, Federico , Sainz, Juan , Horst, Rob ter , García-Martín, Paloma, Cerhan, James R. , Chen-Liang, Tzu-Hua , Norman, Aaron D. , Luppi, Mario , Slager, Susan L. , Netea, M. G.

Mayo Clinic

International Journal of Molecular Sciences | April 28, 2023 | Volume: 24 | Issue: 9 | Pages: 8005

10.3390/ijms24098005 | PMID 37175717 Get It

Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults worldwide. Although genome-wide association studies (GWAS) have uncovered the germline genetic component underlying CLL susceptibility, the potential use of GWAS-identified risk variants to predict disease progression and patient survival remains unexplored. Here, we evaluated whether 41 GWAS-identified risk variants for CLL could influence overall survival (OS) and disease progression, defined as time to first treatment (TTFT) in a cohort of 1039 CLL cases ascertained through the CRuCIAL consortium. Although this is the largest study assessing the effect of GWAS-identified susceptibility variants for CLL on OS, we only found a weak association of ten single nucleotide polymorphisms (SNPs) with OS (p < 0.05) that did not remain significant after correction for multiple testing. In line with these results, polygenic risk scores (PRSs) built with these SNPs in the CRuCIAL cohort showed a modest association with OS and a low capacity to predict patient survival, with an area under the receiver operating characteristic curve (AUROC) of 0.57. Similarly, seven SNPs were associated with TTFT (p < 0.05); however, these did not reach the multiple testing significance threshold, and the meta-analysis with previous published data did not confirm any of the associations. As expected, PRSs built with these SNPs showed reduced accuracy in prediction of disease progression (AUROC = 0.62). These results suggest that susceptibility variants for CLL do not impact overall survival and disease progression in CLL patients.
The genetic determinants of recurrent somatic mutations in 43,693 blood genomes
Weinstock, Joshua S. , Laurie, Cecelia , Broome, Jai , Taylor, Kent D. , Guo, Xiuqing , Shuldiner, Alan R. , O’Connell, Jeffrey R. , Lewis, Joshua P. , Boerwinkle, Eric , Barnes, Kathleen C. , Chami, Nathalie , Loos, Ruth J. F. , Fornage, Myriam , Redline, Susan , Cade, Brian E. , Chen, Zhanghua , Gauderman, W. James , Schleimer, Robert P. , Bis, Joshua C. , Brody, Jennifer A. , Silverman, Edwin K. , Qiao, Dandi , Lasky‐Su, Jessica , DeMeo, Dawn L. , Palmer, Nicholette D. , Bowden, Donald W. , Johnson, Andrew D. , Yanek, Lisa R. , Becker, Lewis C. , Kardia, Sharon L.R., Kaplan, Robert C. , Heckbert, Susan R. , Smith, Nicholas L. , Arnett, Donna K. , Irvin, Marguerite R. , Tiwari, Hemant K., Raffield, Laura M. , Gao, Yan , Rotter, Jerome I. , Wheeler, Marsha M. , Duggirala, Ravindranath , Xiao, Shujie, Williams, L. Keoki , Meyers, Deborah A. , Ortega, Victor E. , McGarvey, Stephen T. , Chen, Yii‐Der Ida , Lee, Wen‐Jane , Shoemaker, M. Benjamin , Roden, Dan M. , Blackwell, Thomas W. , Smith, Albert V. , Kang, Hyun Min , Mathias, Rasika A. , Natarajan, Pradeep , Jaiswal, Siddhartha , Reiner, Alex P. , Bick, Alexander G. , Kaplan, Robert C. , Broome, Jai , Kenny, Eimear E , Loos, Ruth J F , Fornage, Myriam , Redline, Susan , Cade, Brian E , Gauderman, W James , Grammer, Leslie , Schleimer, Robert P , Bis, Joshua C , Brody, Jennifer A , Silverman, Edwin K , Yun, Jeong H , Qiao, Dandi , Weiss, Scott T , Palmer, Nicholette D , Freedman, Barry I , Cho, Michael H , Vasan, Ramachandran S , Johnson, Andrew D , Yanek, Lisa R , Becker, Lewis C , He, Jiang , Heckbert, Susan R , Wiggins, Kerri L , Arnett, Donna K , Correa, Adolfo , Raffield, Laura M , Gao, Yan , Rotter, Jerome I , Rich, Stephen S , Manichaikul, Ani W , Konkle, Barbara A , Johnsen, Jill M , Custer, Brian S , Duggirala, Ravindranath , Curran, Joanne E , Li, Xingnan , McGarvey, Stephen T , Gu, C Charles , Lee, Wen-Jane , Darbar, Dawood , Roden, Dan M. , Kooperberg, Charles , Desai, Pinkal M , Smith, Albert V , Kang, Hyun M , Mathias, Rasika A , Natarajan, Pradeep , Jaiswal, Siddhartha , Bick, Alexander G , Weinstock, Joshua S , Shuldiner, Alan R , Taylor, Kent D , Guo, Xiuqing , Lasky-Su, Jessica , Gilliland, Frank D. , Kumar, Rajesh , Psaty, Bruce M. , Yun, Jeong H. , Weiss, Scott T. , Freedman, Barry I. , Cho, Michael H. , Vasan, Ramachandran S. , He, Jiang , Wiggins, Kerri L. , Andrade, Mariza de , Rich, Stephen S. , Manichaikul, Ani , Konkle, Barbara A. , Custer, Brian , Curran, Joanne E. , Blangero, John , Gui, Hongsheng , Li, Xingnan , Darbar, Dawood , Albert, Christine M. , Kooperberg, Charles , Desai, Pinkal , Abecasis, Gonçalo R.

Mayo Clinic

Science Advances | April 26, 2023 | Volume: 9 | Issue: 17 | Pages: No page available

10.1126/sciadv.abm4945 | PMID 37126548 Get It

Nononcogenic somatic mutations are thought to be uncommon and inconsequential. To test this, we analyzed 43,693 National Heart, Lung and Blood Institute Trans-Omics for Precision Medicine blood whole genomes from 37 cohorts and identified 7131 non-missense somatic mutations that are recurrently mutated in at least 50 individuals. These recurrent non-missense somatic mutations (RNMSMs) are not clearly explained by other clonal phenomena such as clonal hematopoiesis. RNMSM prevalence increased with age, with an average 50-year-old having 27 RNMSMs. Inherited germline variation associated with RNMSM acquisition. These variants were found in genes involved in adaptive immune function, proinflammatory cytokine production, and lymphoid lineage commitment. In addition, the presence of eight specific RNMSMs associated with blood cell traits at effect sizes comparable to Mendelian genetic mutations. Overall, we found that somatic mutations in blood are an unexpectedly common phenomenon with ancestry-specific determinants and human health consequences.
Cohort study examining associations between ceramide levels and risk of multimorbidity among persons participating in the Mayo Clinic Biobank
Rocca, Walter A. , Sohn, Sunghwan , Weston, Susan A., McGree, Michaela E. , St Sauver, Jennifer L , Rocca, Walter A , Bielinski, Suzette , Sauver, Jennifer L. St. , LeBrasseur, Nathan K. , Olson, Janet E. , Bielinski, Suzette J. , Mielke, Michelle M.

Mayo Clinic

BMJ Open | April 21, 2023 | Volume: 13 | Issue: 4 | Pages: e069375

10.1136/bmjopen-2022-069375 | PMID 37085302 Get It

Objective Ceramides have been associated with several ageing-related conditions but have not been studied as a general biomarker of multimorbidity (MM). Therefore, we determined whether ceramide levels are associated with the rapid development of MM. Design Retrospective cohort study. Setting Mayo Clinic Biobank. Participants 1809 persons in the Mayo Clinic Biobank ≥65 years without MM at the time of enrolment, and with ceramide levels assayed from stored plasma. Primary outcome measure Persons were followed for a median of 5.7 years through their medical records to identify new diagnoses of 20 chronic conditions. The number of new conditions was divided by the person-years of follow-up to calculate the rate of accumulation of new chronic conditions. Results Higher levels of C18:0 and C20:0 were associated with a more rapid rate of accumulation of chronic conditions (C18:0 z score RR: 1.30, 95% CI: 1.10 to 1.53; C20:0 z score RR: 1.26, 95% CI: 1.07 to 1.49). Higher C18:0 and C20:0 levels were also associated with an increased risk of hypertension and coronary artery disease. Conclusions C18:0 and C20:0 were associated with an increased risk of cardiometabolic conditions. When combined with biomarkers specific to other diseases of ageing, these ceramides may be a useful component of a biomarker panel for predicting accelerated ageing.
Neuromuscular ultrasound standardized scanning techniques and protocols: Expert panel recommendations
Tawfik, Eman A. , Cartwright, Michael S. , Alfen, Nens van , Axer, Hubertus , Boon, Andrea J. , Grimm, Alexander , Hobson‐Webb, Lisa D., Kerasnoudis, Antonios , Mandeville, Ross , Preston, David C. , Sakamuri, Sarada, Shin, Susan , Shook, Steven J. , Walker, Francis O. , van Alfen, Nens , Crump, Nicholas , Kerasnoudis, Antonios , Preston, David C , Shin, Susan , Crump, Nicholas , Shahrizaila, Nortina , Wilder‐Smith, Einar

Mayo Clinic

Muscle & Nerve | April 19, 2023 | Volume: 68 | Issue: 4 | Pages: 375-379

10.1002/mus.27830 | PMID 37074101 Get It

AbstractNeuromuscular ultrasound has become an integral part of the diagnostic workup of neuromuscular disorders at many centers. Despite its growing utility, uniform standard scanning techniques do not currently exist. Scanning approaches for similar diseases vary in the literature creating heterogeneity in the studies as reported in several meta‐analysis. Moreover, neuromuscular ultrasound experts including the group in this study have different views with regards to technical aspects, scanning protocols, and the parameters that should be assessed. Establishing standardized neuromuscular scanning protocols is essential for the development of the subspeciality to ensure uniform clinical and research practices. Therefore, we aimed to recommend consensus‐based standardized scanning techniques and protocols for common neuromuscular disorders using the Delphi approach. A panel of 17 experts participated in the study, which consisted of three consecutive electronic surveys. The first survey included voting on six scanning protocols addressing the general scanning technique and five common categories of suspected neuromuscular disorders. The subsequent surveys focused on refining the protocols and voting on new steps, rephrased statements, or areas of non‐agreement. A high degree of consensus was achieved on the general neuromuscular ultrasound scanning technique and the scanning protocols for focal mononeuropathies, brachial plexopathies, polyneuropathies, amyotophic lateral sclerosis, and muscle diseases. In this study, a group of neuromuscular ultrasound experts developed six consensus‐based neuromuscular ultrasound scanning protocols that may serve as references for clinicians and researchers. The standardized protocols could also aid in achieving high‐quality uniform neuromuscular ultrasound practices.
Needs-based novel digital curriculum for the neuromodulation training deficit: Pain Rounds
Durbhakula, Shravani , Toy, Serkan , Acosta, C. , Barman, Ross , Kelner, Andrew F, Issa, Mohammad A. , Broachwala, Mustafa , Marascalchi, Bryan J. , Navalgund, Yeshvant A, Pak, Daniel , Petersen, Erika , Moeschler, Susan M. , Kohan, Lynn , Barman, Ross A , Mehta, Neel D , Kohan, Lynn R , Acosta, Carlos A

Mayo Clinic

Regional Anesthesia & Pain Medicine | April 13, 2023 | Volume: 48 | Issue: 8 | Pages: 414-419

10.1136/rapm-2023-104480 | PMID 37055185 Get It

This study reports the needs-based development, effectiveness and feasibility of a novel, comprehensive spinal cord stimulation (SCS) digital curriculum designed for pain medicine trainees. The curriculum aims to address the documented systematic variability in SCS education and empower physicians with SCS expertise, which has been linked to utilization patterns and patient outcomes. Following a needs assessment, the authors developed a three-part SCS e-learning video curriculum with baseline and postcourse knowledge tests. Best practices were used for educational video production and test-question development. The study period was from 1 February 2020 to 31 December 2020. A total of 202 US-based pain fellows across two cohorts (early-fellowship and late-fellowship) completed the baseline knowledge assessment, while 122, 96 and 88 participants completed all available post-tests for Part I (Fundamentals), Part II (Cadaver Lab) and Part III (Decision Making, The Literature and Critical Applications), respectively. Both cohorts significantly increased knowledge scores from baseline to immediate post-test in all curriculum parts (p<0.001). The early-fellowship cohort experienced a higher rate of knowledge gain for Parts I and II (p=0.045 and p=0.027, respectively). On average, participants viewed 6.4 out of 9.6 hours (67%) of video content. Self-reported prior SCS experience had low to moderate positive correlations with Part I and Part III pretest scores (r=0.25, p=0.006; r=0.37, p<0.001, respectively). Initial evidence suggests that Pain Rounds provides an innovative and effective solution to the SCS curriculum deficit. A future controlled study should examine this digital curriculum’s long-term impact on SCS practice and treatment outcomes.
Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience
Gregory, Timothy A. , Mastall, Max , Lin, Heather , Hess, Kenneth R. , Yuan, Ying , García, Manuela Martín-Bejarano , Alfaro, Kristin D, Gule-Monroe, Maria , Khatua, Soumen , Rao, Ganesh , Sandberg, David I. , Yeboa, D.N. , McGovern, Susan L. , Zaky, Wafik , Mahajan, Anita , Suki, Dima , Weathers, Shiao‐Pei , Puduvalli, Vinay K. , Peñas-Prado, Marta , Majd, Nazanin , Puduvalli, Vinay K , Fuller, Gregory N. , Huse, Jason T. , Wefel, Jeffrey S. , Paulino, Arnold C. , Harrison, Rebecca A , Groot, John de

Mayo Clinic

Neuro-Oncology Advances | April 13, 2023 | Volume: 5 | Issue: 1 | Pages: No page available

10.1093/noajnl/vdad032 | PMID 37114244 Get It

Abstract Background Medulloblastoma in adults is rare and treatment decisions are largely driven from pediatric literature. We sought to characterize recurrent medulloblastoma in adults. Methods From a single-institution dataset of 200 adult patients diagnosed with medulloblastoma during 1978–2017, those with recurrence were analyzed for clinical features, treatment, and outcome. Results Of the 200 patients, 82 (41%) with median age of 29 years (18–59) had recurrence after a median follow-up time of 8.4 years (95% CI = 7.1, 10.3). Of these, 30 (37%) were standard-risk, 31 (38%) were high-risk, and 21 (26%) had unknown-risk diseases at the time of initial diagnosis. Forty-eight (58%) presented with recurrence outside the posterior fossa, of whom 35 (43%) had distant recurrence only. Median Progression-free survival (PFS) and OS from initial surgery were 33.5 and 62.4 months, respectively. Neither PFS nor OS from initial diagnosis differed between the standard-risk and high-risk groups in those who experience recurrence (P = .505 and .463, respectively). Median OS from first recurrence was 20.3 months, also with no difference between the standard-risk and high-risk groups (P = .518). Recurrences were treated with combinations of re-resection (20 patients; 25%), systemic chemotherapy (61 patients; 76%), radiation (29 patients; 36%), stem cell transplant (6 patients; 8%), and intrathecal chemotherapy (4 patients; 5%). Patients who received radiation at recurrence had better OS (32.9 months) than those who did not (19.2 months) (P = .034). Conclusions Recurrent medulloblastoma in adults has a poor prognosis irrespective of initial risk stratification. Recurrence commonly arises outside the posterior fossa years after initial diagnosis.